THE EFFICACY OF SILYMARIN IN DECREASING TRANSAMINASE ACTIVITIES IN NON-ALCOHOLIC FATTY LIVER DISEASE: A RANDOMIZED CONTROLLED CLINICAL TRIAL

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

HAJAGHA MOHAMMADI A.A.; ZIAEI AMIR; RAFIEI R.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: Hepatitis Monthly Year:2008 | Volume:8 | Issue:3 Page(s): 191-195

Download Full-Text

View:

1,706

Download:

1,593

Cites:

Information Journal Paper

Title

THE EFFICACY OF SILYMARIN IN DECREASING TRANSAMINASE ACTIVITIES IN NON-ALCOHOLIC FATTY LIVER DISEASE: A RANDOMIZED CONTROLLED CLINICAL TRIAL

Author(s)

HAJAGHA MOHAMMADI A.A. | ZIAEI AMIR | RAFIEI R. | Issue Writer Certificate

Keywords

NON-ALCOHOLIC FATTY LIVER DISEASE

NON-ALCOHOLIC STEATOHEPATITIS

SILYMARIN

Abstract

Background and Aims: NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) is one of the most common causes of increased liver enzymes. According to statistical reports, 20%-40% of Western population and 5%-30% of the population of Pacific and Asian countries are afflicted with this disease. The prevalence of NAFLD is higher in hyperlipidemic, diabetic and obese people. Considering the high prevalence of NAFLD and its complications and lack of consensus on its treatment, we were motivated to study the efficacy of SILYMARIN on this disease. Methods: In this randomized clinical trial, 50 patients including 32 men (64%) and 18 women (36%) were divided into case and control groups. The mean age of case group was 40.3 and for control group was 39.9 years. All patients had elevated liver enzymes and had increased liver echogenicity (lipid accumulation) on sonography. The case group was treated with one tablet containing 140 mg SILYMARIN per day for two months and the control group was treated in the same manner with placebo. Before and after the study, weight, body mass index (BMI) and liver transaminases levels were measured for each patient. Results: The difference between the mean weight and BMI measured before and after the study was not statistically significant in both case and control groups. But the mean ALT and AST levels deceased from 103.1 to 41.4 and 53.7 to 29.1 IU/mL, respectively in case group which was statistically significant (P<0.001 & P<0.001). In the control group, the decrease in mean ALT and AST, with decrease of 7.8 and 2.2 IU/mL, respectively, was not statistically significant. Conclusions: Considering the significant drop in liver enzymes following administration of SILYMARIN, it seems that after conducting similar studies in order to determine the appropriate doses and treatment periods, this cheap and easy to access drug can be prescribed for treatment of NAFLD.

Cites

No record.

References

No record.

Cite

APA: Copy

HAJAGHA MOHAMMADI, A.A., ZIAEI, AMIR, & RAFIEI, R.. (2008). THE EFFICACY OF SILYMARIN IN DECREASING TRANSAMINASE ACTIVITIES IN NON-ALCOHOLIC FATTY LIVER DISEASE: A RANDOMIZED CONTROLLED CLINICAL TRIAL. HEPATITIS MONTHLY, 8(3), 191-195. SID. https://sid.ir/paper/306182/en

Vancouver: Copy

HAJAGHA MOHAMMADI A.A., ZIAEI AMIR, RAFIEI R.. THE EFFICACY OF SILYMARIN IN DECREASING TRANSAMINASE ACTIVITIES IN NON-ALCOHOLIC FATTY LIVER DISEASE: A RANDOMIZED CONTROLLED CLINICAL TRIAL. HEPATITIS MONTHLY[Internet]. 2008;8(3):191-195. Available from: https://sid.ir/paper/306182/en

IEEE: Copy

A.A. HAJAGHA MOHAMMADI, AMIR ZIAEI, and R. RAFIEI, “THE EFFICACY OF SILYMARIN IN DECREASING TRANSAMINASE ACTIVITIES IN NON-ALCOHOLIC FATTY LIVER DISEASE: A RANDOMIZED CONTROLLED CLINICAL TRIAL,” HEPATITIS MONTHLY, vol. 8, no. 3, pp. 191–195, 2008, [Online]. Available: https://sid.ir/paper/306182/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops